https://www.selleckchem.com/pr....oducts/pdd00017273.h
The results of internal 5-fold cross-validation confirmed the usefulness of CYP1A1 and CYP1B1 inhibition data for the threshold-based discrimination of DILI drugs. Although the contribution of these P450s to drug metabolism in the liver is considered minimal, our present findings suggest that the assessment of CYP1A1 and CYP1B1 inhibition is useful for screening DILI risk of drug candidates at the early stage of drug development.Enniatins are so-called "emerging mycotoxins" that commonly occur in milligrams per kilogram levels in gr
Like
Comment
Share
